-
1
-
-
0027419049
-
Association of Langerhans cell histiocytosis with malignant neoplasms
-
Egeler RM, Neglia J, Pucetti DM, et al. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer. 1993;71:865-873.
-
(1993)
Cancer
, vol.71
, pp. 865-873
-
-
Egeler, R.M.1
Neglia, J.2
Pucetti, D.M.3
-
2
-
-
0028301082
-
Acute leukemia in association with Langerhans cell histiocytosis
-
Egeler RM, Neglia JP, Arico M, et al. Acute leukemia in association with Langerhans cell histiocytosis. Med Pediatr Oncol. 1994;23:81-85.
-
(1994)
Med Pediatr Oncol.
, vol.23
, pp. 81-85
-
-
Egeler, R.M.1
Neglia, J.P.2
Arico, M.3
-
3
-
-
0028275643
-
A treatment strategy for disseminated langerhans cell histiocytosis
-
Gadner H, Heitger A, Grois N, et al. A treatment strategy for disseminated langerhans cell histiocytosis. Med Pediatr Oncol. 1994;23:72-80.
-
(1994)
Med Pediatr Oncol.
, vol.23
, pp. 72-80
-
-
Gadner, H.1
Heitger, A.2
Grois, N.3
-
4
-
-
0026703948
-
Vergleich der alleinigen chemotherapie mit der allogenen knochenmarkstransplantation in erster vollremission bei kindern mit akuter myeloischer leukämie in den studien AML-BFM-83 und AML-BFM-87
-
Creutzig U, Bender-Götze C, Klingebiel T, et al. Vergleich der alleinigen Chemotherapie mit der allogenen Knochenmarkstransplantation in erster Vollremission bei Kindern mit akuter myeloischer Leukämie in den Studien AML-BFM-83 und AML-BFM-87. Klin Pädiatr. 1992;204:246-252.
-
(1992)
Klin Pädiatr.
, vol.204
, pp. 246-252
-
-
Creutzig, U.1
Bender-Götze, C.2
Klingebiel, T.3
-
5
-
-
0028050043
-
Verbesserung der lokalen tumorkontrolle durch einen frühen und risikoadaptierten einsatz der radiotherapie bei primär nicht resektablen rhabdomyosarkomen: Ergebnisse der CWS-81 und 86 studien
-
Koscielniak E, Herbst M, Niethammer T, Treuner J. Verbesserung der lokalen Tumorkontrolle durch einen frühen und risikoadaptierten Einsatz der Radiotherapie bei primär nicht resektablen Rhabdomyosarkomen: Ergebnisse der CWS-81 und 86 Studien. Klin Pädiatr. 1994;206:269-276.
-
(1994)
Klin Pädiatr.
, vol.206
, pp. 269-276
-
-
Koscielniak, E.1
Herbst, M.2
Niethammer, T.3
Treuner, J.4
-
6
-
-
0026607302
-
Epipodophyllotoxins, alkylating agents and radiation and risk of secondary leukemia after childhood cancer
-
Hawkins MM, Kinnier Wilson LM, Stovall MA, et al. Epipodophyllotoxins, alkylating agents and radiation and risk of secondary leukemia after childhood cancer. BMJ. 1992;304:951-958.
-
(1992)
BMJ
, vol.304
, pp. 951-958
-
-
Hawkins, M.M.1
Kinnier Wilson, L.M.2
Stovall, M.A.3
-
7
-
-
0026584519
-
Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure
-
Levine E, Bloomfield C. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol. 1992;19:47-84.
-
(1992)
Semin Oncol.
, vol.19
, pp. 47-84
-
-
Levine, E.1
Bloomfield, C.2
-
8
-
-
0021166099
-
Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases
-
Pedersen-Bjegaard J, Philip P, Pedersen NT, et al. Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. Cancer. 1984;54:452-462.
-
(1984)
Cancer
, vol.54
, pp. 452-462
-
-
Pedersen-Bjegaard, J.1
Philip, P.2
Pedersen, N.T.3
-
9
-
-
0028229192
-
Acute promyelocytic leukemia in a patient treated with etoposide for Langerhans cell histiocytosis
-
Matsuzaki A, Inamitsu T, Watanabe T, et al. Acute promyelocytic leukemia in a patient treated with etoposide for Langerhans cell histiocytosis. Br J Haematol. 1994;86:887-889.
-
(1994)
Br J Haematol.
, vol.86
, pp. 887-889
-
-
Matsuzaki, A.1
Inamitsu, T.2
Watanabe, T.3
-
10
-
-
0028332667
-
Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: Estimating the risk
-
Smith MA, Rubinstein L, Ungerleider RS. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risk. Med Pediatr Oncol. 1994;23:86-98.
-
(1994)
Med Pediatr Oncol.
, vol.23
, pp. 86-98
-
-
Smith, M.A.1
Rubinstein, L.2
Ungerleider, R.S.3
-
12
-
-
0027993777
-
Treatment of Langerhans cell histiocytosis: Evolution and current approaches
-
Ladisch S, Gadner H. Treatment of Langerhans cell histiocytosis: evolution and current approaches. Br J Cancer. 1994;70:41-46.
-
(1994)
Br J Cancer
, vol.70
, pp. 41-46
-
-
Ladisch, S.1
Gadner, H.2
-
13
-
-
0030185202
-
Etoposide in Langerhans cell histiocytosis
-
Gadner H. Etoposide in Langerhans cell histiocytosis. Pediatr Hematol Oncol. 1996;13:309-311.
-
(1996)
Pediatr Hematol Oncol.
, vol.13
, pp. 309-311
-
-
Gadner, H.1
-
14
-
-
0022914279
-
Therapy-related leukemia and myelodysplastic syndrome: Clinical, cytogenetic and prognostic features
-
Kantarjian HM, Keating MJ, Walters RS, et al. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic and prognostic features. J Clin Oncol. 1986;4:1748-1757.
-
(1986)
J Clin Oncol.
, vol.4
, pp. 1748-1757
-
-
Kantarjian, H.M.1
Keating, M.J.2
Walters, R.S.3
-
15
-
-
0021797464
-
Therapy-related acute myeloid leukemia and myelodysplastic syndrome: A clinical and morphologic study of 65 cases
-
Michels SD, McKenna RW, Arthur DC, Brunning RD. Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases. Blood. 1985;65:1364-1372.
-
(1985)
Blood
, vol.65
, pp. 1364-1372
-
-
Michels, S.D.1
McKenna, R.W.2
Arthur, D.C.3
Brunning, R.D.4
-
16
-
-
0345494954
-
Acute promyelocytic leukemia following etoposide-based combination chemotherapy for Letterer-Siewe disease
-
Kitabayashi T, Sekiguchi N, Yanai M, et al. Acute promyelocytic leukemia following etoposide-based combination chemotherapy for Letterer-Siewe disease. Jpn J Pediatr Haematol. 1992;6:232-236.
-
(1992)
Jpn J Pediatr Haematol.
, vol.6
, pp. 232-236
-
-
Kitabayashi, T.1
Sekiguchi, N.2
Yanai, M.3
-
17
-
-
0027134789
-
Acute promyelocytic leukemia with t (15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis
-
Horibe K, MatsushitaT, Shin-Ichiro N, et al. Acute promyelocytic leukemia with t (15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis. Cancer. 1993;72:3723-3726.
-
(1993)
Cancer
, vol.72
, pp. 3723-3726
-
-
Horibe, K.1
Matsushita, T.2
Shin-Ichiro, N.3
-
18
-
-
0028018901
-
Increased risk of secondary leukemia after single-agent treatment with etoposide for Langerhans cell histiocytosis
-
Haupt R, Fears TR, Rosso P, et al. Increased risk of secondary leukemia after single-agent treatment with etoposide for Langerhans cell histiocytosis. Pediatr Hematol Oncol. 1994;11:499-507.
-
(1994)
Pediatr Hematol Oncol.
, vol.11
, pp. 499-507
-
-
Haupt, R.1
Fears, T.R.2
Rosso, P.3
-
19
-
-
0030932613
-
Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans cell histiocytosis in Italian and Austrian-German populations
-
Haupt R, Fearf TR, Heise A, et al. Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans cell histiocytosis in Italian and Austrian-German populations. Int J Cancer. 1997;71: 9-13.
-
(1997)
Int J Cancer
, vol.71
, pp. 9-13
-
-
Haupt, R.1
Fearf, T.R.2
Heise, A.3
|